Skip to content

Topical Lidocaine After Major Arthroscopic Knee Surgery

Topical Lidocaine Patch Does Not Have an Analgesic Effect After Major Arthroscopic Knee Surgery. A Double-blind Place-controlled Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01509729
Enrollment
21
Registered
2012-01-13
Start date
2011-06-30
Completion date
2012-01-31
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Patella, Pain

Keywords

Knee, Arthroscopy, Lidocaine patch, Pain management after knee arthroscopy

Brief summary

Pain after major arthroscopic surgery is dependent on an optimal multimodal analgesic treatment.

Detailed description

Lidocaine is well-known as analgesic treatment on skin and hypodermic veins. Since 1996 it has been documented that topical lidocaine has an analgesic effect 24 hours after surgical treatment. The aim is to determine a possible reduction in pain after knee arthroscopy with topical lidocaine.

Interventions

A randomized group of patients received a placebo patch. As a supplement, each patient was given a dose of morphine, as required.

PROCEDUREKnee arthroscopic surgery

A randomized group of patients was given small patches with active 5% lidocaine.

Sponsors

Northern Orthopaedic Division, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who were planned for reconstruction of anterior crucial ligament, reconstruction of medial patellofemoral ligament and Elmslie-Trillat procedure for patella instability. * Patients with synovectomies and menisci resection lasting more than 25 minutes. * Patients \> 18 years * Acceptance of informed consent

Exclusion criteria

* Patients with rheumatoid arthritis * Patients with a Body Mass index of \> 35 * Patients who can not read and understand Danish * Fertile women who does not use secure contraception

Design outcomes

Primary

MeasureTime frameDescription
Administration of analgesic drugs24 hoursTime for the first necessary administration of analgesic drugs.

Secondary

MeasureTime frameDescription
Pain management after surgical treatment24 hoursThe intake of necessary analgesic drugs after 6, 12, 18 and 24 hours after surgical treatment. Pain score according to the VAS scale when the patients rest and make movements.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026